🇺🇸 FDA
Patent

US 7384909

Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 7384909 (Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents) held by The Board of Regents of the University of Texas System expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
64
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62